Sarepta Therapeutics SRPT spent $160K on lobbying in Q1 2023 · Health Issues, Taxation

Trade details

Type: Lobbying report
Amount: $160,000
Quarter: Q1 2023
Stock: Sarepta Therapeutics SRPT
Client: Sarepta Therapeutics
Reported: 23/04/18

Down 11.1% from last quarter

What else happened in Sarepta Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Sarepta Therapeutics's other lobbying reports

Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$50K
$50K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$90K
$90K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$220K
$220K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$110K
$110K
Reported 04/20
for Q1
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$270K
$270K
Reported 04/20
for Q1

Sarepta Therapeutics SRPT spent $160K on lobbying in Q1 2023 · Health Issues, Taxation | Whalegun